These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 7196513)
61. Urinary MHPG is not a good predictor of antidepressive drug response. Puzyński S; Rode A; Bidziński A; Mrozek S; Załuska M Pol J Pharmacol Pharm; 1984; 36(4):329-35. PubMed ID: 6527968 [TBL] [Abstract][Full Text] [Related]
63. Growth hormone catecholamines in affective disease. Garver DL; Pandey GN; Dekirmenjian H; Deleon-Jones F Am J Psychiatry; 1975 Nov; 132(11):1149-54. PubMed ID: 1166891 [TBL] [Abstract][Full Text] [Related]
64. Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders. Schatzberg AF; Samson JA; Bloomingdale KL; Orsulak PJ; Gerson B; Kizuka PP; Cole JO; Schildkraut JJ Arch Gen Psychiatry; 1989 Mar; 46(3):260-8. PubMed ID: 2783211 [TBL] [Abstract][Full Text] [Related]
65. Toward a biochemical classification of depressive disorders IV: Pretreatment urinary MHPG levels as predictors of antidepressant response to imipramine. Schatzberg AF; Orsulak PJ; Rosenbaum AH; Maruta T; Kruger ER; Cole JO; Schildkraut JJ Commun Psychopharmacol; 1980; 4(5):441-5. PubMed ID: 7333096 [No Abstract] [Full Text] [Related]
66. [Selective study of sulfate and glucuronide conjugates of urinary MHPG in nervous depression. Peripheral and central influences]. Peyrin L; Pequignot JM; Chauplannaz G; Laurent B; Moindrot J; Aimard G Encephale; 1985; 11(1):19-24. PubMed ID: 3996286 [TBL] [Abstract][Full Text] [Related]
67. Urinary 3-methoxy-4-hydroxyphenethylene glycol in the prediction of pain and depression relief with doxepin: preliminary findings. Ward NG; Bloom VL; Fawcett J; Friedel RO J Nerv Ment Dis; 1983 Jan; 171(1):55-8. PubMed ID: 6848650 [TBL] [Abstract][Full Text] [Related]
68. Urinary MHPG-sulfate and urinary MHPG-glucuronide, two possible markers of the central or peripheral norepinephrine metabolism in man. The effect of alprazolam treatment. Müller WE; Bauer K; Rost W; Filser JG; Fischer M; Gattaz WF Pharmacopsychiatry; 1988 Nov; 21(6):371-3. PubMed ID: 3244770 [No Abstract] [Full Text] [Related]
69. Biological markers in depression. Monoamine metabolites in urine of depressed patients and normal subjects. Vandel S; Vandel B; Bonin B; Camejo Z; Sandoz M; Allers G; Volmat R Pharmacopsychiatry; 1985 Nov; 18(6):347-50. PubMed ID: 2418451 [TBL] [Abstract][Full Text] [Related]
70. Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline. Schatzberg AF; Rosenbaum AH; Orsulak PJ; Rohde WA; Maruta T; Kruger ER; Cole JO; Schildkraut JJ Psychopharmacology (Berl); 1981; 75(1):34-8. PubMed ID: 6795656 [TBL] [Abstract][Full Text] [Related]
71. Apparent phase advance in diurnal MHPG rhythm in depression. Gwirtsman HE; Halaris AE; Wolf AW; DeMet E; Piletz JE; Marler M Am J Psychiatry; 1989 Nov; 146(11):1427-33. PubMed ID: 2817113 [TBL] [Abstract][Full Text] [Related]
72. MHPG excretion during sleep deprivation in endogenous depression. Matussek N; Römisch P; Ackenheil M Neuropsychobiology; 1977; 3(1):23-9. PubMed ID: 895995 [TBL] [Abstract][Full Text] [Related]
73. Methodological issues in the measurement of urinary MHPG. Muscettola G; Potter WZ; Gordon EK; Goodwin FK Psychiatry Res; 1981 Jun; 4(3):267-76. PubMed ID: 6943594 [TBL] [Abstract][Full Text] [Related]
74. Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants. Mooney JJ; Schatzberg AF; Cole JO; Samson JA; Waternaux C; Gerson B; Pappalardo KM; Schildkraut JJ J Clin Psychopharmacol; 1991 Dec; 11(6):339-43. PubMed ID: 1770151 [TBL] [Abstract][Full Text] [Related]
75. Failure to correlate urinary MHPG with clinical response to amitriptyline. Puzyński S; Rode A; Bidziński A; Mrozek S; Załuska M Psychopharmacol Bull; 1984; 20(1):171-3. PubMed ID: 6718644 [No Abstract] [Full Text] [Related]
76. Possible pathophysiological mechanisms in subtypes of unipolar depressive disorders based on differences in urinary MHPG levels [proceedings]. Schildkraut JJ; Orsulak PJ; Schatzberg AF; Cole JO; Rosenbaum AH Psychopharmacol Bull; 1981 Jan; 17(1):90-91. PubMed ID: 7232668 [No Abstract] [Full Text] [Related]
77. Platelet MAO inhibition, urinary MHPG, and leukocyte beta-adrenergic receptors in depressed patients treated with phenelzine. Sharma RP; Janicak PG; Javaid JI; Pandey GN; Gierl B; Davis JM Am J Psychiatry; 1990 Oct; 147(10):1318-21. PubMed ID: 2169208 [TBL] [Abstract][Full Text] [Related]
78. Reduction by propranolol of raised urinary output of MHPG in hyperactive rats. Speiser Z; Weinstock M Pharmacol Biochem Behav; 1976 May; 4(5):531-4. PubMed ID: 951432 [TBL] [Abstract][Full Text] [Related]
79. Urinary 3-methoxy-4-hydroxyphenylglycol in affective and schizophrenic patients. Behavior and symptom correlates. Mueser KT; Rosen AJ; Javaid JI; Davis JM Neuropsychobiology; 1986; 15(2):57-61. PubMed ID: 3093916 [TBL] [Abstract][Full Text] [Related]
80. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test. Roy A; Jimerson DC; Pickar D Am J Psychiatry; 1986 Jul; 143(7):846-51. PubMed ID: 3717423 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]